Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLAGL2 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | GPR176 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | RNF11 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | QDPR | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | PLA1A | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | UNC13A | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | ANKRD34A | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | LIN28B | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | CREB3 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | UTP14C | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |